MCM
PRCT icon

MAI Capital Management’s Procept Biorobotics PRCT Stock Holding History

MAI Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,531
Closed -$88.3K – 4033
2026
Q1 		$88.3K Buy
3,531
+1,939
+122% +$54.6K ﹤0.01% 1908
2025
Q4 		$50.1K Buy
1,592
+78
+5% +$2.59K ﹤0.01% 2009
2025
Q3 		$54K Buy
1,514
+8
+0.5% +$365 ﹤0.01% 1874
2025
Q2 		$86.7K Sell
1,506
-190
-11% -$10.7K ﹤0.01% 1555
2025
Q1 		$98.8K Hold
1,696
– – ﹤0.01% 1418
2024
Q4 		$137K Buy
+1,696
New +$145K ﹤0.01% 1296

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

MAI Capital Management's PRCT Position: Q2 2026 in Review

MAI Capital Management sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 3,531 shares — an estimated $88.3K sold.

MAI Capital Management first reported a position in PRCT in Q4 2024 and held it in 6 quarters. The position peaked at $137K in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • MAI Capital Management reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 3,531 Procept Biorobotics shares in Q2 2026, an estimated $88.3K.
  • MAI Capital Management first reported a position in Procept Biorobotics in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's Procept Biorobotics position peaked at $137K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.